New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Dechra Pharmaceuticals PLC
DPH.L
Shape
US Flag

LSE

Unprofitable

Unprofitable

4B

Drug Manufacturers - General

3866.00GBP
Shape2.00 ( 0.05%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-86%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

7%

Quote Panel

Shape
Updated October 10, 2024
1W % 1M % 3M % 1Y 1.84 %

Key Metrics

Shape
  • Market Cap

    4.40B


  • Shares Outstanding

    113.91M


  • Share in Float

    112.53M


  • Dividende

    0.45


  • Earning Date

    No Data


  • Price Target

    3866


  • Average Volume

    1.36M


  • Beta

    0.781


  • Range

    0.0-4145.837


  • Industry

    Drug Manufacturers - General


  • Website

    https://www.dechra.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

5.78x

P/S Ratio

5.83x

P/B Ratio

0.7

Debt/Equity

-3.7%

Net Margin

$-0.3

EPS

How DPH.L compares to sector?

P/E Ratio

Relative Strength

Shape

DPH.L

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$899M

Shape9%

2025-Revenue

$1.05

Shape22%

2025-EPS

$68M

Shape9%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.21

arrow
arrow

+81%

0.15
vs 0.08

Q2.21

arrow
arrow

+81%

0.15
vs 0.08

Q3.21

arrow
arrow

+128%

0.19
vs 0.08

Q4.21

arrow
arrow

+74%

0.19
vs 0.11

Q1.22

arrow
arrow

-46%

0.08
vs 0.15

Q2.22

arrow
arrow

-46%

0.08
vs 0.15

Q3.22

arrow
arrow

-47%

0.1
vs 0.19

Q4.22

arrow
arrow

N/A

-0.22
vs 0.19

Q1.23

arrow
arrow

N/A

NA
vs 0.08

Q2.23

arrow
arrow

N/A

-0.22
vs 0.08

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.21

arrow
arrow

+20%

154.1M  vs 128.8M

Q3.21

arrow
arrow

+29%

166.2M  vs 128.8M

Q4.21

arrow
arrow

+11%

166.2M  vs 149.9M

Q1.22

arrow
arrow

+13%

174.7M  vs 154.1M

Q2.22

arrow
arrow

+13%

174.7M  vs 154.1M

Q3.22

arrow
arrow

+14%

188.7M  vs 166.2M

Q4.22

arrow
arrow

+14%

188.7M  vs 166.2M

Q1.23

arrow
arrow

+10%

192.1M  vs 174.7M

Q2.23

arrow
arrow

+10%

192.1M  vs 174.7M

Q3.23

arrow
arrow

+306%

765.3M  vs 188.7M

Return on EquityShape

status-upQoQ

Q3.21

arrow
arrow

+13%

0.13
vs 0.03

Q4.21

arrow
arrow

+3%

0.03
vs 0.13

Q1.22

arrow
arrow

+5%

0.05
vs 0.03

Q2.22

arrow
arrow

+1%

0.01
vs 0.05

Q3.22

arrow
arrow

+1%

0.01
vs 0.01

Q4.22

arrow
arrow

+1%

0.01
vs 0.01

Q1.23

arrow
arrow

-3%

-0.03
vs 0.01

Q2.23

arrow
arrow

-3%

-0.03
vs -0.03

Institutionnal OwnershipShape

status-upQoQ

Q4.21

arrow
arrow

1

1
vs 1

NA

Q1.22

arrow
arrow

1

1
vs 1

NA

Q2.22

arrow
arrow

1

1
vs 1

NA

Q3.22

arrow
arrow

1

1
vs 1

NA

Q4.22

arrow
arrow

1

1
vs 1

NA

Q1.23

arrow
arrow

1

1
vs 1

NA

Q2.23

arrow
arrow

1

1
vs 1

NA

Q3.23

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News